✦ LIBER ✦

221 A randomized phase II trial of pegylated arginine deaminase (ADI-PEG 20) in patients with malignant pleural mesothelioma

✍ Scribed by Szlosarek, P.W.; Fennell, D.A.; Rudd, R.M.; Lind, M.; Ranson, M.; Hackshaw, A.; Bomalaski, J.S.; Steele, J.P.C.

Book ID: 118573904
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 48 KB
Volume: 54
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(07)70297-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of pegylated arginine d

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma

✍ Ott, Patrick A.; Carvajal, Richard D.; Pandit-Taskar, Neeta; Jungbluth, Achim A. 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 490 KB

A randomised phase II study of pegylated

A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients

✍ Yang, T-S; Lu, S-N; Chao, Y; Sheen, I-S; Lin, C-C; Wang, T-E; Chen, S-C; Wang, J 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 431 KB

221 A phase II trial to assess the safet

221 A phase II trial to assess the safety and immunological activity of TroVax plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma. The SKOPOS trial

✍ Lester, J.F.; Casbard, A.; Roberts, K.; Tabi, Z.; Griffiths, G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 51 KB

A phase II trial of prolonged, continuou

A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma

✍ Arrieta, Oscar; López-Macías, Diego; Mendoza-García, Víctor-Osvaldo; Bacon-Fonse 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 428 KB

Cisplatin in combination with irinotecan

Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma : A pilot phase II clinical trial and pharmacokinetic profile

✍ Takashi Nakano; A. Philippe Chahinian; Miho Shinjo; Naoki Togawa; Atsushi Tonomu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB 👁 2 views

The purpose of this study was to assess the efficacy and toxicity of a combination of cisplatin and irinotecan (CPT-11) in the treatment of patients with malignant pleural mesothelioma and to characterize the pharmacokinetic profiles of CPT-11 and its active metabolite, 7-ethyl-10-hydroxycamptotheci